SPARQL
Downloads
Documentation/Help
Skip Header
Results
Your Query
Add common prefixes
DESCRIBE <http://purl.uniprot.org/SHA-384/DDD6864B16454E0DA84198829FF4B039B36FAE45A91FF9F53EB2B27CEF3E617A8081F88E5042A57E70C6B359B75EA206>
Submit Query
Cancel
RDF/XML
NTriples
Turtle
Show query
Share
Subject
Predicate
Object
http://purl.uniprot.org/SHA-384/DDD6864B16454E0DA84198829FF4B039B36FAE45A91FF9F53EB2B27CEF3E617A8081F88E5042A57E70C6B359B75EA206
http://www.w3.org/1999/02/22-rdf-syntax-ns#type
http://purl.uniprot.org/core/Annotation
http://purl.uniprot.org/SHA-384/DDD6864B16454E0DA84198829FF4B039B36FAE45A91FF9F53EB2B27CEF3E617A8081F88E5042A57E70C6B359B75EA206
http://www.w3.org/2000/01/rdf-schema#comment
"Results indicate that TM4SF5-mediated epithelial-mesenchymal transition may have an important function in the gefitinib resistance of cancer cells."
xsd:string
http://purl.uniprot.org/uniprot/#_6DE93E72D5DF081272D4DE4D8385B1FF594F99EFB6E43F4E92946D4D37B737C41130FCF5045A38B69E52E78A552A5517
http://www.w3.org/1999/02/22-rdf-syntax-ns#subject
http://purl.uniprot.org/SHA-384/DDD6864B16454E0DA84198829FF4B039B36FAE45A91FF9F53EB2B27CEF3E617A8081F88E5042A57E70C6B359B75EA206
http://purl.uniprot.org/uniprot/O14894
http://purl.uniprot.org/core/mappedAnnotation
http://purl.uniprot.org/SHA-384/DDD6864B16454E0DA84198829FF4B039B36FAE45A91FF9F53EB2B27CEF3E617A8081F88E5042A57E70C6B359B75EA206
http://purl.uniprot.org/uniprot/#_O14894-mappedCitation-22178131
http://purl.uniprot.org/core/mappedAnnotation
http://purl.uniprot.org/SHA-384/DDD6864B16454E0DA84198829FF4B039B36FAE45A91FF9F53EB2B27CEF3E617A8081F88E5042A57E70C6B359B75EA206